CMPI.org

In the News

On Assignment: Bitter Pill

06/17/2016 12:00 AM | NBC Dateline

360 Degree Global Trade and the Urgent Need for the Trans-Pacific Partnership

05/11/2016 12:00 AM | CMPI

FDA takes step to improve generic drug competition

03/15/2016 12:00 AM | Marketplace

Single-payer health care unworkable, too costly

03/07/2016 12:00 AM | Philadelphia Inquirer

Congress must protect vital drug patents from Wall Street attacks

01/14/2016 12:00 AM | Morrow County Sentinel

James P. Pinkerton, Cures Strategy founder, Fox News Analyst, and Reagan White House alumni, Joins CMPI

01/05/2016 12:00 AM | CMPI

States copying market-based Medicare plan

12/03/2015 12:00 AM | Philly.com

Obamacare's slippery slope to single-payer system

12/03/2015 12:00 AM | CNBC

Outlook 2014: Capitol Commotion

12/02/2015 12:00 AM | Medical Marketing and Media

Hillary’s vaccine price plan didn’t work the first time for a reason

10/18/2015 12:00 AM | New York Post

Why People Don't Trust Drug Makers

09/24/2015 12:00 AM | New York Post

‘Patent Death Squads’ vs. Innovation

06/10/2015 12:00 AM | The Wall Street Journal

NYTimes Letter to the Editor: Drug Shortages Continue to Vex

02/10/2015 12:00 AM |

Foreign meds, quality control

05/28/2014 12:00 AM | Worcester Telegram

Federal funds should go to medicine-makers

05/11/2014 12:00 AM | Chicago Tribune

America’s pain and opioid problem

05/01/2014 12:00 AM | The Washington Times

Stop meddling with Medicare

04/14/2014 12:00 AM | Birmingham News

Peter Pitts Discusses Expedited Reviews and the Current State of Drug Development

03/31/2014 12:00 AM | Context Matters

Drug shortage policies still come up short

03/07/2014 12:00 AM | Birmingham News

A health care revolution threatened

02/19/2014 12:00 AM | The Orange County Register

Previous
1
...
5
6
7
8
9
Next

RECENT NEWS

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Journal of Commercial Biotechnology
09/02/2021 12:00 AM

Waiving COVID-19 Vaccine Patents: A Bad Idea and a Dangerous Precedent

Waiving patent protection discourages cutting-edge research investments, which in turn produce breakthrough treatments no... Read more

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Sky News
06/07/2021 12:00 AM

'I'm hopeful for the future': Alzheimer's drug approved by FDA

Peter Pitts of CMPI and Dr. Ronald Petersen of the Mayo Clinic discuss the FDA's approval of aducanumab... Read more

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

FDLI
09/07/2021 12:00 AM

Biosimilar Strength vs. Potency: Avoiding a Regulatory Hobson’s Choice

Biosimilars bring lower costs and greater access to the market for biological products, but FDA must determine a predicta... Read more

Read all News